Successful treatment of systemic lupus erythematosus pleuropericarditis with belimumab

Abstract   Systemic lupus erythematosus (SLE) is characterized by a wide variety of manifestations and a difficult disease control in some patients. We present the case of a 51-year-old woman who presented with a flare of SLE including arthritis and pleuropericarditis that responded to neither leflu...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of rheumatology Vol. 6; no. 3; pp. 150 - 152
Main Authors Carrión-Barberà, Irene, Salman-Monte, Tarek Carlos, Castell, Sonia, Castro-Domínguez, Francisco, Ojeda, Fabiola, Monfort, Jordi
Format Journal Article
LanguageEnglish
Published Turkey AVES Yayincilik A.S 01.07.2019
Medical Research and Education Association
AVES
Subjects
Arthritis
Belimumab
Case-based Review
Corticosteroids
Drug therapy
Health aspects
Lupus
Prednisone
Systemic lupus erythematosus
Online AccessGet full text
ISSN2148-4279
2147-9720
2148-4279
DOI10.5152/eurjrheum.2019.17169

Cover

More Information
Summary:Abstract   Systemic lupus erythematosus (SLE) is characterized by a wide variety of manifestations and a difficult disease control in some patients. We present the case of a 51-year-old woman who presented with a flare of SLE including arthritis and pleuropericarditis that responded to neither leflunomide, methotrexate, nor high doses of prednisone. After initiating treatment with belimumab, the patient experienced a quick and notorious improvement. She remains stable to this day while continuing belimumab therapy.     Cite this article as: Carrión-Barberà I, Salman-Monte TC, Castell S, Castro-Domínguez F, Ojeda F, Monfort J. Successful treatment of systemic lupus erythematosus pleuropericarditis with belimumab. Eur J Rheumatol 2019; 6(3): 150-2.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:2148-4279
2147-9720
2148-4279
DOI:10.5152/eurjrheum.2019.17169